 Administration, Intravaginal
"Administration, Intravaginal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
| Descriptor ID |
D000282
|
| MeSH Number(s) |
E02.319.267.120.500
|
| Concept/Terms |
Administration, Intravaginal- Administration, Intravaginal
- Vaginal Administration
- Administrations, Vaginal
- Vaginal Administrations
- Administration, Vaginal
- Intravaginal Administration
- Administrations, Intravaginal
- Intravaginal Administrations
Instillation, Vaginal- Instillation, Vaginal
- Instillations, Vaginal
- Vaginal Instillation
- Vaginal Instillations
- Vaginal Drug Administration
- Drug Administration, Vaginal
- Administration, Vaginal Drug
- Administrations, Vaginal Drug
- Drug Administrations, Vaginal
- Vaginal Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravaginal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravaginal".
This graph shows the total number of publications written about "Administration, Intravaginal" by people in this website by year, and whether "Administration, Intravaginal" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text, click here.
Below are the most recent publications written about "Administration, Intravaginal" by people in Profiles.
-
Young IC, Srinivasan P, Shrivastava R, Janusziewicz R, Thorson A, Cottrell ML, Sellers RS, Sykes C, Schauer A, Little D, Kelley K, Kashuba ADM, Katz D, Pyles RB, Garc?a-Lerma JG, Vincent KL, Smith J, Benhabbour SR. Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy. Biomaterials. 2023 10; 301:122260.
-
Heyborne K. Reassessing Preterm Birth Prevention After the Withdrawal of 17-a Hydroxyprogesterone Caproate. Obstet Gynecol. 2023 09 01; 142(3):493-501.
-
Guthrie KM, Rosen RK, Guillen M, Ramirez JJ, Vargas SE, Fava JL, Ham AS, Katz DF, Cu-Uvin S, Tumilty S, Smith KA, Buckheit KW, Buckheit RW. Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use. AIDS Res Hum Retroviruses. 2022 07; 38(7):601-610.
-
Baker Z, Javanbakht M, Moore J, Brosnan H, Squires K, Bunge K, Zimet G, Mensch B, Soto-Torres L, Kapogiannis B, Levy L, Hoesley C, Reirden D, Gaur A, Mayer K, Futterman D, Gorbach P. Qualitative Study on the Acceptability of and Adherence to a Vaginal Ring for HIV Prophylaxis Among Adolescent Girls. J Acquir Immune Defic Syndr. 2021 07 01; 87(3):944-950.
-
Mirkin S, Simon JA, Liu JH, Archer DF, Castro PD, Graham S, Bernick B, Komm B. Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert. Menopause. 2021 05 28; 28(9):998-1003.
-
Guthrie KM, Fava JL, Vargas SE, Rosen RK, Shaw JG, Kojic EM, Ham AS, Rohan LC, Katz D, Paname?o A, Colleran C, Friend DF, Buckheit KW, Buckheit RW. The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal Sex. AIDS Res Hum Retroviruses. 2020 12; 36(12):1059-1070.
-
Crandall CJ, Diamant A, Santoro N. Safety of vaginal estrogens: a systematic review. Menopause. 2020 03; 27(3):339-360.
-
Bauermeister JA, Golinkoff JM, Carballo-Di?guez A, Giguere R, L?pez D, Hoesley CJ, Chen BA, Anderson P, Dezzutti CS, Strizki J, Sprinkle C, Heard F, Hall W, Jacobson C, Berthiaume J, Mayo A, Richardson BA, Piper J. A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027. AIDS Behav. 2020 Feb; 24(2):607-616.
-
Keller MJ, Wood L, Billingsley JM, Ray LL, Goymer J, Sinclair S, McGinn AP, Marzinke MA, Frank B, Srinivasan S, Liu C, Atrio JM, Espinoza L, Mugo N, Spiegel HML, Anderson PL, Fredricks DN, Hendrix CW, Marrazzo J, Bosinger SE, Herold BC. Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial. Lancet HIV. 2019 08; 6(8):e498-e508.
-
Govil S, Katz DF. Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood. Sci Rep. 2019 01 14; 9(1):82.
|
Similar Concepts
![expand description]()
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|